AlphaValue Corporate Services
Cette analyse a été commandée et financée par l’entreprise concernée et constitue donc un avantage non-monétaire mineur tel que défini par MIFID2

Cementir Holding

CR
Bloomberg   CEM IM
Ciments & Agrégats  /  Italie  Web Site   |   Investors Relation
Egalement présent dans : Sociétés holdings
Competitive pricing but lower cost supports profitability
Objectif
Potentiel 64,5 %
Cours (€) 6,2
Capi (M€) 987
Perf. 1S: -2,97 %
Perf. 1M: 8,39 %
Perf. 3M: 7,27 %
Perf Ytd: -23,9 %
Perf. relative/stoxx600 10j: -5,42 %
Perf. relative/stoxx600 20j: -3,15 %
EPS change24/03/2020

Changement d’EPS2020 : € 0,56 vs 0,65-14,3 %
2021 : € 0,61 vs 0,77-20,1 %

We have updated our model with the FY19 results. The company performed better than we had anticipated, especially in Turkey, where we priced in the impact of the country's economic strains and devaluation of lira too conservatively. Despite the company's great performance in 2019, we have narrowed our estimates for 2020 and 2021, due to the COVID-19 pandemic. We have only marginally reduced the EPS for 2020 and 2021 because they were already low as compared to the updated 2019 level. However, the company has not communicated anything about the impact of COVID-19, except for the fact that the operations in China are already regaining momentum. Thus, for the moment, our current assumptions are based on a wet finger approach and we will make further changes once the company communicates on the impact and possibly a fresh set of targets during Q1 20 results.



Changement de DCF€ 10,2 vs 12,0-14,9 %

Along with the change in earnings, we have increased the debt spread to 300bp. We have also changed the EBITDA growth to 1.5% from 2% in the out years because COVID-19 has added an extra layer of uncertainity to the earnings growth, on the already existent ETS Phase IV (Emission Trading Scheme) apprehension.



Mises à Jour

10 mars 21 Publication Res./CA
FY20 results - a Turkish Delight

05 févr. 21 Publication Res./CA
FY 20: performance beyond full-year guidance

29 juil. 20 Publication Res./CA
H1 20: in for a Danish treat

14 mai 20 Publication Res./CA
Q1 20: lower result but good shareholder remu...

Next123Next
.